Clinical and economic outcomes for patients initiating fluticasone propionate/salmeterol combination therapy (250/50 mcg) versus anticholinergics in a comorbid COPD/depression population

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is frequently associated with comorbid depression and anxiety. Managing COPD symptoms and exacerbations through use of appropriate and adequate pharmacotherapy in this population may result in better COPD-related outcomes. METHODS: This retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalal, Anand A, Shah, Manan, D’Souza, Anna O, Chaudhari, Sham, Crater, Glenn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273366/
https://www.ncbi.nlm.nih.gov/pubmed/22315518
http://dx.doi.org/10.2147/COPD.S27846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273366/
https://www.ncbi.nlm.nih.gov/pubmed/22315518
http://dx.doi.org/10.2147/COPD.S27846

Ejemplares similares